Columbia University researchers have identified a link between serotonin signaling and the progression of degenerative mitral regurgitation, a condition where the heart's mitral valve fails to close properly. The work suggests that certain patients face accelerated valve deterioration based on genetic and medication interactions.
The study examined patients with the condition who carry a specific genetic variant affecting serotonin receptors. Researchers found that those taking selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressants, showed faster progression of valve damage compared to patients without the genetic variant or those not taking SSRIs. This acceleration could push patients toward surgical intervention at younger ages than typical.
Degenerative mitral regurgitation affects millions globally and represents one of the most frequent valve conditions requiring surgery. The disease develops gradually as the valve weakens over time. While previous research connected serotonin pathway activity to various cardiovascular conditions, this work appears novel in linking SSRI use directly to mitral valve disease progression through genetic predisposition.
The Columbia team's findings carry practical implications for patient management. Clinicians may need to stratify risk based on both genetic screening and medication history. For patients carrying the relevant genetic variant, alternative antidepressant classes could offer protection against accelerated valve damage, though researchers emphasized the importance of individualized treatment decisions that weigh depression management against cardiovascular risk.
The discovery highlights how neurotransmitter systems influence organ function beyond the brain. Serotonin receptors exist throughout the cardiovascular system, and their activation can trigger cellular changes in valve tissues. Understanding these mechanisms could lead to targeted therapies that either block harmful serotonin signaling in susceptible patients or stabilize valve function independently.
Limitations include the need for larger prospective studies to confirm these findings and determine the precise molecular mechanisms. The research team called for additional